Home » Emma Thomas, DPhil

Emma Thomas, DPhil

Analyst

Emma Thomas, DPhil, is an Analyst at CBPartners

Connect with Emma Thomas, DPhil

emma.thomas@cbpartners.com

LinkedIn

Published Articles

Drug Assessment Uncertainties: HTA Bodies vs. Regulators

A recent study of the review of new medicines by regulatory and HTA bodies has revealed areas of misalignment in their processes, highlighting unique challenges in the pathway to patient access.